Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04106011 · ClinicalTrials.gov registry record
Cognitive Changes With Gabapentin Treatment
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04106011 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 3 participants.
The verdict
NCT04106011 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is a single-cohort, prospective, observational study evaluating the effects of gabapentin on cognition. The goal of the study is to determine whether there is a measurable change in cognitive function from baseline in patients who are prescribed gabapentin for the treatment of neuropathic pain.
Interventions
- DRUG Gabapentin
- DIAGNOSTIC_TEST BTACT
- DIAGNOSTIC_TEST BPI
- DIAGNOSTIC_TEST HADS
- DIAGNOSTIC_TEST SLP9
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2021-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04106011
The ClinicalTrials.gov registry entry for NCT04106011 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Gabapentin is the first listed.
NCT04106011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04106011 about?
NCT04106011 is a clinical study titled "Cognitive Changes With Gabapentin Treatment". This is a single-cohort, prospective, observational study evaluating the effects of gabapentin on cognition. The goal of the study is to determine whether there is a measurable change in cognitive function from baseline in patients who are prescribed gabapentin for the treatment of neuropathic pain.
What is the current status of trial NCT04106011?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2020-01-10. Estimated completion is 2021-02-18.
What interventions are being tested in trial NCT04106011?
The interventions under investigation include: Gabapentin (DRUG), BTACT (DIAGNOSTIC_TEST), BPI (DIAGNOSTIC_TEST), HADS (DIAGNOSTIC_TEST), SLP9 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04106011?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.